Editorial Comment to Palonosetron with aprepitant plus dexamethasone to prevent chemotherapy-induced nausea and vomiting during gemcitabine/cisplatin in urothelial cancer patients

Int J Urol. 2015 Oct;22(10):915. doi: 10.1111/iju.12870. Epub 2015 Jul 7.

Authors

Antonio Rozzi¹, Gaetano Lanzetta²

Affiliations

¹ Medical Oncology Unit, Istituto Neurotraumatologico Italiano (I.N.I.), Rome, Italy. antoniorozzi@virgilio.it.
² Medical Oncology Unit, Istituto Neurotraumatologico Italiano (I.N.I.), Rome, Italy.

PMID: 26153730
DOI: 10.1111/iju.12870

No abstract available

Publication types

Editorial
Comment

MeSH terms

Antiemetics / therapeutic use*
Antineoplastic Combined Chemotherapy Protocols / adverse effects*
Carcinoma, Transitional Cell / drug therapy*
Female
Humans
Male
Nausea / prevention & control*
Serotonin Antagonists / therapeutic use*
Urologic Neoplasms / drug therapy*
Vomiting / prevention & control*

Substances

Antiemetics
Serotonin Antagonists